scispace - formally typeset
P

Peter Tomasec

Researcher at Cardiff University

Publications -  47
Citations -  4137

Peter Tomasec is an academic researcher from Cardiff University. The author has contributed to research in topics: Human cytomegalovirus & MHC class I. The author has an hindex of 28, co-authored 45 publications receiving 3745 citations. Previous affiliations of Peter Tomasec include University of Wales.

Papers
More filters
Journal ArticleDOI

Surface Expression of HLA-E, an Inhibitor of Natural Killer Cells, Enhanced by Human Cytomegalovirus gpUL40

TL;DR: It is shown that, independently of the transporter associated with antigen processing, gpUL40 can up-regulate expression of HLA-E, which protects targets from NK cell lysis, which is up-regulated by HCMV.
Journal ArticleDOI

Quantitative temporal viromics: an approach to investigate host-pathogen interaction.

TL;DR: A systematic quantitative analysis of temporal changes in host and viral proteins throughout the course of a productive infection could provide dynamic insights into virus-host interaction, applicable to any virus with a robust in vitro model.
Journal ArticleDOI

Modulation of natural killer cells by human cytomegalovirus

TL;DR: The mechanisms by which HCMV systematically evades (or, more properly, modulates) NK cell recognition constitutes an area of growing understanding that is enhancing the authors' appreciation of the basic mechanisms of NK cell function in humans.
Journal ArticleDOI

Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication

TL;DR: To overcome rapid emergence of mutations in genetically intact HCMV, a system in which RL13 and UL131A were conditionally repressed during virus propagation is developed, which permits studies to be undertaken with a clonal, characterized H CMV strain containing the complete wild-type gene complement.